About Peripherin
Peripherin (PRPH) is a protein
from Homo sapiens identified by UniProt accession
P41219, 470 residues long.
MolForge cross-references it against 0 known binders and
133 disease associations.
Target properties
| Protein name | Peripherin |
| UniProt accession | P41219 |
| Gene | PRPH |
| Organism | Homo sapiens |
| Length | 470 residues |
| Molecular weight | — |
| EC numbers | — |
| Target class | UNCLASSIFIED |
| Subcellular location | — |
| Keywords | — |
Druggability
Target tractability assessment (Open Targets + pocket analysis). No approved drug
| Druggability tier | MEDIUM |
| Druggability score | — |
| Pocket score | — |
| Max clinical phase | — |
Disease associations (133)
Diseases linked to this target (Open Targets).
- familial amyotrophic lateral sclerosis · score 0.59
- sporadic amyotrophic lateral sclerosis · score 0.59
- amyotrophic lateral sclerosis · score 0.35
- prostate carcinoma · score 0.32
- genetic disorder · score 0.19
- mean platelet volume · score 0.14
- platelet count · score 0.13
- platelet component distribution width · score 0.12
- frontotemporal dementia with motor neuron disease · score 0.12
- axial length measurement · score 0.06
3D Structure (1)
Experimental (PDB) and predicted (AlphaFold) structures for this protein.
| Structure | Source | Method | Mean pLDDT | Resolution (Å) |
| AF-P41219-F1 | alphafold | PREDICTED | 78.23 | — |
Amino-acid sequence (470 residues)
MSHHPSGLRA GFSSTSYRRT FGPPPSLSPG AFSYSSSSRF SSSRLLGSAS PSSSVRLGSF RSPRAGAGAL LRLPSERLDF SMAEALNQEF LATRSNEKQE LQELNDRFAN FIEKVRFLEQ QNAALRGELS QARGQEPARA DQLCQQELRE LRRELELLGR ERDRVQVERD GLAEDLAALK QRLEEETRKR EDAEHNLVLF RKDVDDATLS RLELERKIES LMDEIEFLKK LHEEELRDLQ VSVESQQVQQ VEVEATVKPE LTAALRDIRA QYESIAAKNL QEAEEWYKSK YADLSDAANR NHEALRQAKQ EMNESRRQIQ SLTCEVDGLR GTNEALLRQL RELEEQFALE AGGYQAGAAR LEEELRQLKE EMARHLREYQ ELLNVKMALD IEIATYRKLL EGEESRISVP VHSFASLNIK TTVPEVEPPQ DSHSRKTVLI KTIETRNGEV VTESQKEQRS ELDKSSAHSY
Explore Peripherin with MolForge
Find binders, run structure-based screening, and map this target across
diseases and approved drugs with our AI-powered platform.
Browse all targets